Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration
Clinical trial NCT04567303 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04567303
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2026-08-25
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.